1. Home
  2. RDY vs FIVN Comparison

RDY vs FIVN Comparison

Compare RDY & FIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • FIVN
  • Stock Information
  • Founded
  • RDY 1984
  • FIVN 2001
  • Country
  • RDY India
  • FIVN United States
  • Employees
  • RDY N/A
  • FIVN N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • FIVN EDP Services
  • Sector
  • RDY Health Care
  • FIVN Technology
  • Exchange
  • RDY Nasdaq
  • FIVN Nasdaq
  • Market Cap
  • RDY 2.1B
  • FIVN 2.3B
  • IPO Year
  • RDY N/A
  • FIVN 2014
  • Fundamental
  • Price
  • RDY $13.24
  • FIVN $25.30
  • Analyst Decision
  • RDY Buy
  • FIVN Strong Buy
  • Analyst Count
  • RDY 1
  • FIVN 17
  • Target Price
  • RDY $17.00
  • FIVN $56.76
  • AVG Volume (30 Days)
  • RDY 1.9M
  • FIVN 1.6M
  • Earning Date
  • RDY 05-06-2025
  • FIVN 05-01-2025
  • Dividend Yield
  • RDY 3.61%
  • FIVN N/A
  • EPS Growth
  • RDY 2.68
  • FIVN N/A
  • EPS
  • RDY 0.75
  • FIVN N/A
  • Revenue
  • RDY $3,637,607,642.00
  • FIVN $1,041,938,000.00
  • Revenue This Year
  • RDY $17.23
  • FIVN $12.00
  • Revenue Next Year
  • RDY $9.19
  • FIVN $10.97
  • P/E Ratio
  • RDY $17.94
  • FIVN N/A
  • Revenue Growth
  • RDY 14.74
  • FIVN 14.44
  • 52 Week Low
  • RDY $12.50
  • FIVN $24.70
  • 52 Week High
  • RDY $16.89
  • FIVN $63.30
  • Technical
  • Relative Strength Index (RSI)
  • RDY 48.34
  • FIVN 23.76
  • Support Level
  • RDY $13.09
  • FIVN $26.34
  • Resistance Level
  • RDY $13.85
  • FIVN $28.29
  • Average True Range (ATR)
  • RDY 0.14
  • FIVN 1.16
  • MACD
  • RDY 0.02
  • FIVN -0.08
  • Stochastic Oscillator
  • RDY 19.74
  • FIVN 8.41

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About FIVN Five9 Inc.

Five9 offers cloud-native contact center software enabling digital customer service, sales, and marketing engagement. The company's Virtual Contact Center platform combines core telephony functionality, omnichannel engagement, and various modules into a unified cloud contact-center-as-a-service, or CCaaS, platform. Five9's modules include digital self-service, agent assist technology, workflow automation, as well as workforce optimization solutions that optimize call center efficiency, and manage interaction quality and agent performance.

Share on Social Networks: